Technology
Ottawa Backs Vancouver Biotech with $79 Million to Advance 3D-Printed Tissue Therapies
Ottawa commits $79M to Vancouver's Aspect Biosystems, backing a $280M effort to bring 3D-printed human tissue therapies...
